Estimating individual lifetime benefit and bleeding risk with NOAC addition to asprin in stable CVD
In the Cardiovascular Scene Investigation (CSI) series, investigators from Utrecht report at the ESC congress, from the perspective of young investigators. They put a question to researchers about presented study results.
Tamar de Vries, MD – PhD candidate, UMC Utrecht, The Netherlands
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.